44 related articles for article (PubMed ID: 15832512)
1. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis.
Greijer AE; van der Wall E
J Clin Pathol; 2004 Oct; 57(10):1009-14. PubMed ID: 15452150
[TBL] [Abstract][Full Text] [Related]
2. USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.
Mu M; Zhang Q; Li J; Zhao C; Li X; Chen Z; Sun X; Yu J
Cell Death Differ; 2023 Nov; 30(11):2393-2407. PubMed ID: 37816999
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological reactivation of p53 in the era of precision anticancer medicine.
Tuval A; Strandgren C; Heldin A; Palomar-Siles M; Wiman KG
Nat Rev Clin Oncol; 2024 Feb; 21(2):106-120. PubMed ID: 38102383
[TBL] [Abstract][Full Text] [Related]
4. The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer.
Ucaryilmaz Metin C; Ozcan G
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681691
[TBL] [Abstract][Full Text] [Related]
5. The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer.
Zhang C; Liu J; Wang J; Zhang T; Xu D; Hu W; Feng Z
Front Cell Dev Biol; 2021; 9():648808. PubMed ID: 33681231
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53.
Song X; Dilly AK; Choudry HA; Bartlett DL; Kwon YT; Lee YJ
Mol Cancer Res; 2015 Dec; 13(12):1533-43. PubMed ID: 26354682
[TBL] [Abstract][Full Text] [Related]
7. Pre- and posttreatment with edaravone protects CA1 hippocampus and enhances neurogenesis in the subgranular zone of dentate gyrus after transient global cerebral ischemia in rats.
Lei S; Zhang P; Li W; Gao M; He X; Zheng J; Li X; Wang X; Wang N; Zhang J; Qi C; Lu H; Chen X; Liu Y
ASN Neuro; 2014; 6(6):. PubMed ID: 25388889
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3: a novel protein in cerebellar hemangioblastoma.
Al-Salam S; Al-Salam M; Al Ashari M
Int J Clin Exp Pathol; 2013; 6(5):853-61. PubMed ID: 23638216
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal influence of the p53 and the hypoxic pathways.
Sermeus A; Michiels C
Cell Death Dis; 2011 May; 2():e164. PubMed ID: 21614094
[TBL] [Abstract][Full Text] [Related]
10. Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage.
Betigeri S; Zhang M; Garbuzenko O; Minko T
Drug Deliv Transl Res; 2011 Feb; 1(1):13-24. PubMed ID: 21461383
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of early--but not late--expressed HIF-1α is neuroprotective in rats after focal ischemic brain damage.
Yeh SH; Ou LC; Gean PW; Hung JJ; Chang WC
Brain Pathol; 2011 May; 21(3):249-62. PubMed ID: 21029239
[TBL] [Abstract][Full Text] [Related]
12. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors.
Sowter HM; Ratcliffe PJ; Watson P; Greenberg AH; Harris AL
Cancer Res; 2001 Sep; 61(18):6669-73. PubMed ID: 11559532
[TBL] [Abstract][Full Text] [Related]
13. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
14. [Cellular and tissue hypoxia--role of the von Hippel Lindau gene and hypoxia-inducible factor-1].
Sýkora V; Necas E
Cas Lek Cesk; 2003; 142(10):595-8. PubMed ID: 14635422
[TBL] [Abstract][Full Text] [Related]
15. The role of p53 in hypoxia-induced apoptosis.
Hammond EM; Giaccia AJ
Biochem Biophys Res Commun; 2005 Jun; 331(3):718-25. PubMed ID: 15865928
[TBL] [Abstract][Full Text] [Related]
16. Bimodal effect of hypoxia in cancer: role of hypoxia inducible factor in apoptosis.
Wang Y; Pakunlu RI; Tsao W; Pozharov V; Minko T
Mol Pharm; 2004; 1(2):156-65. PubMed ID: 15832512
[TBL] [Abstract][Full Text] [Related]
17. A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug.
Wang Y; Minko T
Biochem Pharmacol; 2004 Nov; 68(10):2031-42. PubMed ID: 15476674
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
